Perfuse Therapeutics, Inc. — Form D

Perfuse Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-29. The offering totals $39.0M, of which $9.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-07-29
• Form: D
• Accession: 0001771941-20-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $39.0M
• Amount sold: $9.0M
• Remaining: $30.0M
• Investors: 8
• Date of first sale: 2020-07-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-372028

Issuer

• Name: Perfuse Therapeutics, Inc.
• CIK: 0001771941
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 1700 OWENS STREET SUITE 540, SAN FRANCISCO, CA, 94158
• Phone: 1-415-272-1083

Officers, directors & promoters (11)

Other filings by this issuer (1)

More

• CIK 1771941 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search